ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business deals

Takeda scares away investors with talk of acquiring Shire

Purchase price could undermine the Japanese drugmaker's finances

TOKYO -- The announcement that Takeda Pharmaceutical is mulling a bid for Irish drugmaker Shire has sent the Japanese company's shares diving.

Investors fear such a large acquisition would put the Japanese company under a heavy debt load and erode its otherwise healthy finances.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more